ArticleFrontiers in nutrition2026
Association between low magnesium status and new-onset dementia in the general population: a propensity score-matched cohort study.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Low magnesium status has been linked to cerebrovascular conditions that overlap with pathways implicated in dementia, yet prior studies have relied on single magnesium measurements obtained in earlier population-based cohorts. Whether repeatedly documented low magnesium status is associated with incident dementia in real-world clinical populations is unclear. Methods: This retrospective propensity score-matched cohort study used data from the TriNetX Global Collaborative Network (2016-2023). Adults aged ≥50 years with two serum magnesium values <1.7 mg/dL within a 1-year window were compared with matched controls with two normal values (1.70-2.20 mg/dL). A 1-year landmark period was applied before the outcome ascertainment. The primary outcome was incident all-cause dementia. The secondary outcomes included dementia subtypes, stroke, and mortality. Prespecified positive and negative control outcomes, subgroup and sensitivity analyses, sequential multivariable Cox regression, and an exploratory analysis of high magnesium status were conducted. Results: After propensity score matching, 162,936 patients were included in each group. Low magnesium status was associated with incident all-cause dementia (HR 1.33; 95% CI, 1.26-1.40, Conclusion: Repeatedly documented low magnesium status was associated with an increased risk of incident all-cause dementia, particularly vascular dementia, suggesting a potential role of magnesium homeostasis in long-term cognitive function.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.